SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-15-067379
Filing Date
2015-09-25
Accepted
2015-09-25 16:10:33
Documents
12
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-K a15-12155_110k.htm 10-K 1381779
2 EX-23.1 a15-12155_1ex23d1.htm EX-23.1 3097
3 EX-31.1 a15-12155_1ex31d1.htm EX-31.1 12971
4 EX-31.2 a15-12155_1ex31d2.htm EX-31.2 12968
5 EX-32.1 a15-12155_1ex32d1.htm EX-32.1 5745
6 EX-32.2 a15-12155_1ex32d2.htm EX-32.2 5744
  Complete submission text file 0001104659-15-067379.txt   4802296

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT ctrv-20150630.xml EX-101.INS 642769
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ctrv-20150630.xsd EX-101.SCH 55930
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ctrv-20150630_cal.xml EX-101.CAL 30901
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ctrv-20150630_def.xml EX-101.DEF 204831
11 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT ctrv-20150630_lab.xml EX-101.LAB 444577
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ctrv-20150630_pre.xml EX-101.PRE 333177
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
ContraVir Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 001-36856 | Film No.: 151125324
SIC: 2834 Pharmaceutical Preparations